Novel Gold-Based Nanocrystals for Medical Treatments and Electrochemical Manufacturing Processes Therefor

A pharmaceutically acceptable suspension comprising:

• a.) pharmaceutical grade water;
• b.) at least one processing enhancer;
• and
• c.) gold nanocrystals suspended in said water forming a suspension, wherein said gold nanocrystals:
• i.) have surfaces that include at least one characteristic selected from the group of characteristics consisting of:
• (1) no organic chemical constituents adhered or attached to said surfaces and (2) are substantially clean and do not have chemical constituents adhered or attached to surfaces, other than water or said processing enhancer, which alter the functioning of said nanocrystals;
• ii.) have a mode particle size of less than about 50 nm;
• iii.) are present in said suspension at a concentration of about 2-200 ppm;
• and
• d.) said suspension having a pH of between about 5 to about 9.5, a zeta potential of at least about −20 mv and the suspension does not contain chlorides.

A pharmaceutical suspension comprising:

• a.) pharmaceutical grade water containing at least one processing enhancer, said water having a pH of between about 5 to about 9.5;
• b.) shaped gold nanocrystals in said water forming said suspension, said suspension having a zeta potential of at least about −20 mV and wherein said gold nanocrystals:
• i.) have surfaces that include at least one characteristic selected from the group of characteristics consisting of:
• (1) no organic chemical constituents adhered or attached to said surfaces and (2) are substantially clean and do not have chemical constituents adhered or attached to surfaces, other than water or said processing enhancer, which alter the functioning of said nanocrystals;
• ii.) have a mode particle size of less than about 50 nm;
• iii.) are present in said suspension at a concentration of about 2-200 ppm;
• and
• iv.) have shapes comprising pentagonal bipyramids and tetrahedrons in a range of about 15% to 50%.

A suspension comprising:

• a.) pharmaceutical grade water containing at least one processing enhancer, said water having a pH of between about 5 to about 9.5;
• b.) gold nanocrystals in said water forming said suspension, said suspension having a zeta potential of at least about −20 mV and wherein said gold nanocrystals:
• i.) have surfaces that include at least one characteristic selected from the group of characteristics consisting of:
• (1) no organic chemical constituents adhered or attached to said surfaces and (2) are substantially clean and do not have chemical constituents adhered or attached to surfaces, other than water or said processing enhancer, which alter the functioning of said nanocrystals;
• ii.) have a mode particle size of less than about 50 nm;
• and
• iii.) are present in said suspension at a concentration of about 2-200 ppm.

A process for forming gold nanoparticles suspended in water:

• providing at least one processing enhancer in said water;
• providing at least one trough member;
• creating a flow direction of said water through said at least one trough member;
• providing at least one metallic-based plasma forming electrode spaced apart from a surface of said water, thereby forming a space between said at least one metallic-based plasma-forming electrode and said surface of said water;
• forming at least one plasma in said space between said at least one metallic-based plasma forming electrode and said surface of said water;
• providing at least one set of electrodes contacting said water, said at least one set of electrodes contacting said water after said water has flowed past said at least one metallic-based plasma forming electrode;
• and
• causing said at least one set of electrodes to react with said water as said water contacts said at least one set of electrodes, whereby said gold nanoparticles are formed in said water.